However, anti-apoptotic Bcl-2 family proteins such as Bcl-2, Bcl-xL, or Mcl-1 prevent the PTP opening and are associated with treatment resistance and progression in many types of cancer, including prostate cancer [15]. This evidence concerns the gene BCL2 and prostate cancer.